56
DAFTAR PUSTAKA
ADA, 2009, Standart of Medical Care in Diabetes-2009,Diabetes Care,32:S13-S61 (Suppl 1).
Anonim, 2007, Penggunaan-Amlodipin-sebagai-Antihipertensi, (online), www.hexpharm jaya.com/page/amlodipin.aspx, diakses tanggal 15 September 2011.
Anonim, 2008. Terapi Antihipertensi dan Efeknya terhadap MetabolismeGlukosa dan Lipid, Farmacia Wahana Komunikasi Lintas Spesialis,Vol.7No.11Juni.http://.majalahFarmacia.com/rubrik/one_new s.asp.IDNews=804, diakses tanggal 15 September 2011.
Anonim, 2009, Tekanan Darah Tinggi (Hipertensi), (online), http://medicastore.com/penyakit/4/Tekanan_Darah_Tinggi_Hipertensi. html , diakses tanggal 4 April 2011.
Basha, A., 2007, Hipertensi: Faktor Risiko dan Penatalaksaanya. www.pjnhk.co.id/artikel22, diakses tanggal 4 April 2011.
Bootman, J.L., Towsend, R.J., and MC Ghan, W.F., 2005, Principle of Pharmacoeconomics, 3ndEd, Appleton and Lange, USA.
BPOM, 2008, Informatorium Obat Nasional Indonesia, Depkes RI, Jakarta. Carter, B, L., and Saseen, J, J., 2005, Hypertension, dalam Dipiro, J.T.,
Towsend, R.L., Yee, G.C., Matzke, G.R., Wells, B.C., and Posey, L.M., Pharmacotherapy: A Pathophysiologic Approach, sixth edition, Appleton and Lange, New York. 186-217
Chen, G.J., Ferruci, L., William, P.M.,& Pahor, M., 2005, A Cost-Minimization Analysis of Diuretic-based Antihypertensive Therapy Reducing Cardiovasculer Events in Older Adults With Isolated Systolic Hypertension, in Cost Effectiveness and Resource Allocation, 3:2, http://www.resource allocation.com/content/3/1/12, diakses 4 April 2011.
57
Da Costa, J.S.D.,Fuchs, S.C., Olinto, M.T.A., Gigante, D.P., Menezes, A.M.B., Macedo, S., Gehrke, S., 2002, Cost Effektiviness of Hipertension treatment: a population-based study, Universidade Federal de Pelotas de Pelotos, Pelotos, Rio Grande do Sul, Brazil Sao Paulo Medical Journal. Vol.120 no.4, Brazil. Diakses 11 April 2011 Depkes, 2006, Pharmaceutical Care Untuk Penyakit Hipertensi, 12-26,
Direktorat Bina Farmasi Komunitas dan Klinik Ditjen Bina Kefarmasian dan Alat Kesehatan Departemen Kesehatan, Jakarta. Gregory, M.C., Odell, T.W., , 1995, J Gen Inter Med, Cost of hypertension
treatment, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, USA. Des 10 (12). 686-8. http://www.ncbi.nlm.nih.gov/pubmed/9220694 diakses 15 September 2011
Kountz, D.S., 1997, J Natl Med Assoc, Cost containment for treating hypertension in African Americans: Impact of a Combined ACE Inhibitor-Calcium Channel Blocker, Division of Primary Care, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, USA. 7.457-60. http://www.ncbi.nlm.nih.gov/pubmed/19726018 diakses 15 september 2011.
Mutschler, Ernst, 1991, Dinamika Obat Ed.5 Diterjemahkan oleh Mathilda B.Widianto dan Anna Setiadi Ranti 486, Penerbit ITB, Bandung. 486 Nafrialdi., 2007, Farmakologi dan Terapi Edisi 5, Bagian Farmakologi
Fakultas Kedokteran Universitas Indonesia, Jakarta. 342-368
Neil, S.S., Jonathan, D.B., Mathew,C., 2000, Kombinasi Obat Antihipertensi :Rekomendasi untuk Penggunaan, American Family Physician, Abington Memorial Hospital, Jengkintown, Pennsylvania diakses tanggal 12 April 2011.
Neutel, J.M., 2006, The Role of Combination Therapy in the Management of Hypertension, Nephrology Dialysis Transplantation oxford journals, 21, 6, 1469-1473.
Orion, 1997, Pharmacoeconomic Primer and Guide Introduction to Economic Evaluation, Hoesch Marion Rousell Incorporation, Virginia
58
Rosbayani, 2007, Analisis Efektivitas Biaya Penggunaan ACE-I dan Calcium Channel Blocker pada Pasien Hipertensi Rawat Jalan RSU Dr.Sardjito Yogyakarta, Skripsi, Fakultas Farmasi, Universitas Gadjah Mada, Yogyakarta.
Sa,adah ,M., 2010, Analisis Efektivitas Biaya Penggunaan Antihipertensi Pada Pasien Hipertensi Rawat Jalan di Rumah Sakit Umum Pusat Dr.Soeradji Tirtonegoro Klaten Tahun 2009, Skripsi, Fakultas Farmasi, Universitas Muhammadiyah Surakarta, Surakarta
Sanchez, A, L., 2005, Pharmacoeconomic: Principles, Metods, and
Application , dalam Dipiro, J.T., Towsend, R.L., Yee, G.C., Matzke,
G.R., Wells, B.C., and Posey, L.M., Pharmacotherapy: A Pathophysiologic Approach, sixth edition, Appleton and Lange, New York. 1-15.
Saputra, Lyndon, 2010, Intisari Ilmu Penyakit Dalam, Penerbit Binarupa Aksara, Tangerang. 440-441.
Saraswati, Adji, 2010, Terapi Kombinasi pada Hipertensi dengan Penyakit Ginjal, Preventing Vascular Cognitive Impairment in Hypertensive Patiensedisi, Edisi No 09 Vol XXXVI (http:www. Terapi-Kombinas-i pada Hipertensi- dengan Penyakit Ginjal.html) diakses tanggal 15september 2011.
Sukandar, E.Y., Andrajati, R., Sigit, J.I., Adnyana, I.K., Setiadi, A.P., Kusnandar., 2008, ISO Farmakoterapi, Penerbit PT.ISFI, Jakarta. 122-128.
Tjandrawinata, R.R., 2000, Pharmacoeconomics to Its Basics Principles, Dexa Medica.
Tjay, T.H., & Raharja, K., 2007, Obat-Obat Penting Khasiat, Penggunaan dan Efek Sampingnya, Edisi 6, PT Elex Media Komputindo Kelompok Gramedia, Jakarta.
Tjiptoherijanto, L., dan Soesetyo, B., 1994, Ekonomi Kesehatan, Penerbit Rineka Cipta, Jakarta. 115-125.
Trisna, Y, 2007, Aplikasi Farmakoekonomi Dalam Pelayanan Kesehatan, /edisi 3/September-november, (online), (http://www. Media Informasi Farmasi Indonesia.com/Aplikasi Farmakoekonomi Dalam Pelayanan Kesehatan. html diakses tanggal 3 maret 2010)
59
William L., & Wilkins ., 2003. Internasional Society of Hypertension on management of hypertension, World Health Organization,Wolters Kluwer Company,UK. 1983-1989.
Vogenberg, F.R., 2001, Introduction To Applied Pharmacoeconomics, McGraw-Hill Companies, USA.
